| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 137, 185-191, Copyright © 1996 by Endocrine Society
ARTICLES |
JJ Montagne, A Ladram, D Grouselle, P Nicolas and M Bulant
Laboratoire de Bioactivation des Peptides, Institut Jacques Monod, Paris, France.
Endogenous TRH-like products were analyzed in rat testis using a TRH enzyme immunoassay coupled to molecular sieve filtration and HPLC identification. Of the three immunoreactive peptides detected, the two major forms exhibited the same chromatographic properties as synthetic TRH and pGlu-Phe-Pro-NH2. These peptides accounted respectively for 33% and 54% of the total TRH immunoreactivity in the testis. In rat serum, HPLC analysis showed the presence of only one immunoreactive peak with a retention time similar to that of authentic TRH. Ethylene dimethanesulfonate treatment of adult rat was used to assess the effect of Leydig cell destruction on the TRH immunoreactivity content. The concentration of the three TRH immunoreactive peptides fell gradually after treatment and reached a minimum at day 21, where a marked decrease (98%) was observed. At day 41, the regeneration of Leydig cells was achieved, as shown by histochemistry and measurements of serum testosterone and testicular weight. However, no restoration of the TRH immunoreactive content was achieved, the three TRH-related peptides being only detectable in trace amount. On the other hand, no significant change in hypothalamic levels of TRH was observed at any treatment time, indicating that hypothalamic TRH biosynthesis was not influenced by testosterone. By using the indirect immunofluorescence technique, TRH immunoreactive cells were found in the interstitial space of the testis. These results suggest that Leydig cells are the only source of authentic TRH and TRH-like peptides in the rat testis. A paracrine, or autocrine role for these products is suggested.
This article has been cited by other articles:
![]() |
A. J. Ruiz-Alcaraz and J. del Rio-Garcia Characterization of a Circulating N-Extended Form of the Thyrotropin-Releasing Hormone-Like Peptide pGlu-Glu-Pro Amide in Human Plasma J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 6002 - 6007. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Nillni and K. A. Sevarino The Biology of pro-Thyrotropin-Releasing Hormone-Derived Peptides Endocr. Rev., October 1, 1999; 20(5): 599 - 648. [Abstract] [Full Text] |
||||
![]() |
J.-J. Montagne, A. Ladram, P. Nicolas, and M. Bulant Cloning of Thyrotropin-Releasing Hormone Precursor and Receptor in Rat Thymus, Adrenal Gland, and Testis Endocrinology, March 1, 1999; 140(3): 1054 - 1059. [Abstract] [Full Text] |
||||
![]() |
J.-J. Montagne, A. Ladram, D. Grouselle, P. Nicolas, and M. Bulant Thyrotropin-releasing Hormone Immunoreactivity in Rat Adrenal Tissue Is Localized in Mast Cells J. Histochem. Cytochem., December 1, 1997; 45(12): 1623 - 1628. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Klootwijk, E. Sleddens-Linkels, R. D. H. de Boer, C. A. Jansen, R. Autar, W. W. de Herder, E.R. Boeve, T. J. Visser, and W. J. de Greef Renal Clearance of the Thyrotropin-Releasing Hormone-Like Peptide Pyroglutamyl-Glutamyl-Prolineamide in Humans J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 3068 - 3073. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gnessi, A. Fabbri, and G. Spera Gonadal Peptides as Mediators of Development and Functional Control of the Testis: An Integrated System with Hormones and Local Environment Endocr. Rev., August 1, 1997; 18(4): 541 - 609. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |